Grosse Claudia, Noack Petar, Silye Rene
Department of Pathology, Kepler University Hospital, Linz, Austria.
Cytopathology. 2019 Mar;30(2):187-193. doi: 10.1111/cyt.12643. Epub 2018 Nov 28.
The aim of this study was to assess the preoperative tumour grade of pancreatic neuroendocrine neoplasms (panNENs) by determining the Ki-67 index in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) material and to correlate the preoperative tumour grade with the postoperative tumour grade in surgical specimens.
We performed a retrospective review of the institutional pathology database over a 10-year period (2007-2017) to identify all cases of panNENs with corresponding preoperative EUS-FNA cytological material and surgical specimens. Fifteen cases with adequate EUS-FNA material (more than 400 tumour cells on cellblock) were identified. The cytological and histological samples were graded based on the mitotic rate and the Ki-67 index in accordance with the 2017 World Health Organisation grading system for panNENs. The tumour grades determined on EUS-FNA cellblock material were compared with the histological tumour grades.
Mean age at diagnosis was 64.8 ± 12.7 years (range, 38-85 years). The grading scores assigned to the cytological and histological samples were concordant in all 15 (100%) cases. Of those, two (13%) cases were scored as grade 1, nine (60%) cases as grade 2 and four (27%) cases as grade 3 tumours.
Our study shows that tumour grade in patients with PanNENs can be reliably determined by assessing the Ki-67 index in EUS-FNA specimens based on the 2017 World Health Organisation classification and grading system.
本研究旨在通过测定内镜超声引导下细针穿刺抽吸(EUS-FNA)材料中的Ki-67指数来评估胰腺神经内分泌肿瘤(panNENs)的术前肿瘤分级,并将术前肿瘤分级与手术标本中的术后肿瘤分级进行关联。
我们对机构病理数据库进行了为期10年(2007 - 2017年)的回顾性研究,以确定所有伴有相应术前EUS-FNA细胞学材料和手术标本的panNENs病例。共识别出15例具有足够EUS-FNA材料(细胞块上有超过400个肿瘤细胞)的病例。根据有丝分裂率和Ki-67指数,按照2017年世界卫生组织panNENs分级系统对细胞学和组织学样本进行分级。将EUS-FNA细胞块材料确定的肿瘤分级与组织学肿瘤分级进行比较。
诊断时的平均年龄为64.8±12.7岁(范围38 - 85岁)。在所有15例(100%)病例中,细胞学和组织学样本的分级评分一致。其中,2例(13%)病例评分为1级,9例(60%)病例为2级,4例(27%)病例为3级肿瘤。
我们的研究表明,根据2017年世界卫生组织分类和分级系统,通过评估EUS-FNA标本中的Ki-67指数,可以可靠地确定panNENs患者的肿瘤分级。